Neoadjuvant intraperitoneal chemotherapy followed by radical surgery and HIPEC in patients with very advanced gastric cancer and peritoneal metastases: report of an initial experience in a western single center

• Published in: World journal of surgical oncology Vol. 16; no. 1; p. 62
• Main Authors: Fava, Bianca Escorel Costa, da Costa, Jr, Wilson Luiz, Medeiros, Maria Luiza L, Sonagli, Marina, de Castro Ribeiro, Héber Salvador, Diniz, Alessandro L, Godoy, André L, de Farias, Igor C, de Jesus, Victor Hugo Fonseca, Begnami, Maria Dirlei F S, Coimbra, Felipe J F
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 22.03.2018; BioMed Central; BMC
• Subjects: Adult; Analysis; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cancer; Cancer patients; Care and treatment; Case Report; Chemotherapy; Chemotherapy, Cancer, Regional Perfusion - methods; Combined Modality Therapy; Cytoreduction Surgical Procedures - methods; Female; Health aspects; Humans; Hyperthermia, Induced - methods; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local - pathology; Neoplasm Recurrence, Local - therapy; Peritoneal Neoplasms - secondary; Peritoneal Neoplasms - therapy; Prognosis; Retrospective Studies; Stomach cancer; Stomach Neoplasms - pathology; Stomach Neoplasms - therapy; Survival Rate; Treatment outcome
• ISSN: 1477-7819; 1477-7819
• DOI: 10.1186/s12957-018-1363-0

The association of preoperative systemic and intraperitoneal chemotherapy has been described in Eastern patients with very good outcomes in treatment responders. The aim of this paper is to describe the initial results of this multidisciplinary regimen in gastric cancer patients with very advanced peritoneal metastases. We present here the first four cases who received the treatment protocol. They had a baseline PCI between 19 and 33. Two patients had received systemic chemotherapy prior to this regimen. Three of them had significant response and were taken to cytoreductive surgery, while one patient who had 12 cycles of chemotherapy previously showed signs of disease progression and subsequently died. There was no significant postoperative morbidity, and three patients remain alive, two of them with no signs of recurrence. Systemic and intraperitoneal chemotherapy led to a marked response in peritoneal disease extent in our initial experience and allowed three of four patients with very advanced disease to be treated with cytoreductive surgery.